Cargando…
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
BACKGROUND: Clinical trials indicate that the use of fixed-dose combinations (FDCs) is associated with a higher level of treatment adherence and prolonged blood pressure (BP) control. The aim of this study was to document the safety and effectiveness of the FDC olmesartan/amlodipine/hydrochlorothiaz...
Autores principales: | Bramlage, Peter, Fronk, Eva-Maria, Wolf, Wolf-Peter, Smolnik, Rüdiger, Sutton, Gemma, Schmieder, Roland E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275113/ https://www.ncbi.nlm.nih.gov/pubmed/25565857 http://dx.doi.org/10.2147/VHRM.S75380 |
Ejemplares similares
-
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
por: Bramlage, Peter, et al.
Publicado: (2010) -
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
por: Bramlage, Peter, et al.
Publicado: (2013) -
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011) -
Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis
por: Roth, Eli M., et al.
Publicado: (2013) -
Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
por: Schmieder, Roland E, et al.
Publicado: (2009)